FATE
Price
$3.22
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
13 days until earnings call
NXTC
Price
$1.45
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
13 days until earnings call
Ad is loading...

FATE vs NXTC

Header iconFATE vs NXTC Comparison
Open Charts FATE vs NXTCBanner chart's image
Fate Therapeutics
Price$3.22
Change-$0.00 (-0.00%)
Volume$753.34K
CapitalizationN/A
NextCure
Price$1.45
Change-$0.00 (-0.00%)
Volume$13.87K
CapitalizationN/A
View a ticker or compare two or three
FATE vs NXTC Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FATE vs. NXTC commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and NXTC is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (FATE: $3.22 vs. NXTC: $1.45)
Brand notoriety: FATE and NXTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 67% vs. NXTC: 45%
Market capitalization -- FATE: $399.71M vs. NXTC: $38.33M
FATE [@Biotechnology] is valued at $399.71M. NXTC’s [@Biotechnology] market capitalization is $38.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileNXTC’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • NXTC’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and NXTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 5 TA indicator(s) are bullish while NXTC’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 5 bullish, 4 bearish.
  • NXTC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FATE is a better buy in the short-term than NXTC.

Price Growth

FATE (@Biotechnology) experienced а +9.52% price change this week, while NXTC (@Biotechnology) price change was +5.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

FATE is expected to report earnings on Mar 03, 2025.

NXTC is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($400M) has a higher market cap than NXTC($38.3M). NXTC YTD gains are higher at: 27.193 vs. FATE (-13.904). NXTC has higher annual earnings (EBITDA): -60.4M vs. FATE (-176.34M). FATE has more cash in the bank: 305M vs. NXTC (86.4M). NXTC has less debt than FATE: NXTC (5.59M) vs FATE (101M). FATE has higher revenues than NXTC: FATE (12.3M) vs NXTC (0).
FATENXTCFATE / NXTC
Capitalization400M38.3M1,044%
EBITDA-176.34M-60.4M292%
Gain YTD-13.90427.193-51%
P/E RatioN/AN/A-
Revenue12.3M0-
Total Cash305M86.4M353%
Total Debt101M5.59M1,807%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATENXTC
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 18 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
+0.31%
ALLO - FATE
54%
Loosely correlated
-5.61%
ABCL - FATE
53%
Loosely correlated
+2.29%
PRME - FATE
53%
Loosely correlated
-4.04%
CRBU - FATE
52%
Loosely correlated
-5.83%
NTLA - FATE
51%
Loosely correlated
+1.94%
More

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-1.36%
CYTK - NXTC
37%
Loosely correlated
-1.36%
FATE - NXTC
35%
Loosely correlated
+0.31%
ORMP - NXTC
33%
Poorly correlated
-1.23%
GOSS - NXTC
32%
Poorly correlated
-0.77%
LYEL - NXTC
30%
Poorly correlated
-5.60%
More